BioGaia AB logo

BioGaia AB

BIOGY · OTC · Health Technology, Pharmaceuticals: Other · Founded 1990

BioGaia AB engages in the development, marketing, and sale of probiotic products. It operates through the following segments: Pediatrics, Adult Health, and Other. The Pediatrics segment sells drops, oral rehydration solutions, digestive health tablets, and also royalties pertaining to pediatric products.

Current Price
—
Market Cap
—
Return Since Last Split
-11%
Last Split
May 26, 2022
Total Splits
1
Cumulative Multiple
2.5×

What If You Bought BIOGY Earlier?

Investment
Purchase Date (Before Split)
Worth Today
—
250 shares · 2×

Estimate based on split history only. Excludes dividends, fees, taxes, and intraday movement.

Stock Split History

Newest split first. Cumulative multiple = compounded growth within the displayed company lineage.

Split DatePrice BeforeRatioSplit MultipleCumulative
May 26, 2022$9.602499-for-10002.5×2.5×

BioGaia AB Market Cap Timeline

A validated annual market-cap history is unavailable from the current sources. The current market-cap snapshot, when shown above, is not treated as historical evidence. Split markers cover 1 current-security split. Filled dots have market-cap data for that year; hollow dots mark split years outside market-cap source coverage.

Validated annual history unavailable

At least two source-validated annual observations are required before this page draws a market-cap timeline. A current snapshot is not treated as historical trend data.

Recorded split dates

Frequently Asked Questions

BioGaia AB's latest record in the split calendar is a 2499-for-1000 forward split effective 2022-05-26.
Stay in the loop

Never Miss a Stock Split Again

Get personalized stock split alerts. Choose what you receive and how often.

Your email is securely stored. We’ll only contact you about updates you choose. Unsubscribe anytime.